Saturday 17 October 2026 Export RPRX’s income statement to Excel — free account

Royalty Pharma PLC

Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024. In the quarter to June 2026, revenue grew 16.5%, EPS fell 40.0%, free cash flow grew 31.6% and total debt rose 12.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

61.29 1.67 +2.80%

Follow RPRX

Alert me

Market cap: $34.3B
P/E: 42.3×
Fwd P/E: 21.9×
Dividend yield: 1.51%
F-score: 5/9
Altman Z: 1.61
Beneish M: −2.83
Dividend safety: 37/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	26.73	28.62	32.63	38.67
P/S ratio Full definition →		6.48	6.98	8.59	9.84
P/FCF ratio Full definition →		4.44	4.72	17.53	19.05
P/Operating CF Full definition →		21.69	20.08	29.17	34.26
P/B ratio Full definition →		1.58	1.71	2.11	2.55
Price to Tangible BV Full definition →		1.75	1.89	2.32	2.82
EV/Sales Full definition →		9.88	10.48	12.01	13.04
EV/EBITDA Full definition →		14.87	15.65	18.04	21.38
EV/Operating CF Full definition →		9.66	10.01	11.22	11.11
EV/FCF Full definition →		6.77	7.09	24.51	25.25
Quick Ratio Full definition →		1.85	1.05	1.19	1.38
Current Ratio Full definition →		3.48	2.40	2.66	2.80
Net Debt/EBITDA Full definition →		18.32	20.93	14.60	57.16
Debt/Assets Full definition →		46.24%	45.62%	45.20%	45.22%
Debt/Equity Full definition →		0.93	0.92	0.90	0.92
Asset Turnover Full definition →		0.13	0.13	0.13	0.13
Operating CF/Net income Full definition →		2.44	3.92	2.44	40.73
Capex/Depreciation Full definition →		(105.46)	0.00	(51.17)	(27.81)
Interest Coverage Full definition →		5.37	4.12	6.01	1.42
Research and Development Expense of Revenue Full definition →		8.29%	8.12%	6.31%	14.51%
Selling, General and Administrative Expense of Revenue Full definition →		19.49%	26.41%	25.29%	24.01%
Intangible Assets out of Total Assets Full definition →		0.05	0.05	0.05	0.05
Share Based Compensation of Revenue Full definition →		11.96%	20.22%	19.35%	15.88%
Graham Net Nets Full definition →		(0.52)	(0.50)	(0.40)	(0.33)
Graham Number Full definition →		25.72	26.20	27.43	26.78
Earnings Yield Full definition →		3.74%	3.49%	3.06%	2.59%
Free Cash Flow Yield Full definition →		22.53%	21.18%	5.71%	5.25%
Revenue per Share Full definition →		1.41	1.45	1.44	1.51
Operating CF per Share Full definition →		1.63	1.92	1.64	1.64
Capex per Share Full definition →		(2.23)	0.00	(1.04)	(0.56)
Free Cash Flow per Share Full definition →		(0.60)	1.92	0.61	1.07
Cash per Share Full definition →		2.21	1.48	1.39	1.88
Shareholders Equity per Share Full definition →		22.28	22.60	22.75	21.99
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		22.28	22.60	22.75	21.99
Free Cash Flow Full definition →		(259.26)	827.15	265.87	477.44
Working Capital Full definition →		1,318.74	891.88	890.13	1,133.64
Capital Expenditures Full definition →		(961.87)	—	(452.37)	(251.02)
Net Current Asset Value Full definition →		(7,876.88)	(8,377.75)	(8,452.77)	(8,269.49)
EV/EBIT Full definition →		15.16	15.98	18.45	21.88
Capex to Sales Full definition →		1.58	0.00	0.72	0.37
Price to Operating Income Full definition →		9.94	10.65	13.19	16.51
Other line items
Average Receivables Full definition →		26.90	28.14	25.65	29.61
Average Payables Full definition →		31.74	16.39	31.56	27.89
Average Assets Full definition →		18,694.76	18,921.75	18,711.84	19,071.39
Average Common Equity Full definition →		9,939.67	10,028.65	9,862.75	9,644.33

Show all line items

Columns are period end dates

Stockrow Weekly